488 related articles for article (PubMed ID: 12067975)
1. Detection of telomerase inhibitors based on g-quadruplex ligands by a modified telomeric repeat amplification protocol assay.
Gomez D; Mergny JL; Riou JF
Cancer Res; 2002 Jun; 62(12):3365-8. PubMed ID: 12067975
[TBL] [Abstract][Full Text] [Related]
2. NMR-Based model of a telomerase-inhibiting compound bound to G-quadruplex DNA.
Fedoroff OY; Salazar M; Han H; Chemeris VV; Kerwin SM; Hurley LH
Biochemistry; 1998 Sep; 37(36):12367-74. PubMed ID: 9730808
[TBL] [Abstract][Full Text] [Related]
3. TRAP-LIG, a modified telomere repeat amplification protocol assay to quantitate telomerase inhibition by small molecules.
Reed J; Gunaratnam M; Beltran M; Reszka AP; Vilar R; Neidle S
Anal Biochem; 2008 Sep; 380(1):99-105. PubMed ID: 18534183
[TBL] [Abstract][Full Text] [Related]
4. 9-Substituted berberine derivatives as G-quadruplex stabilizing ligands in telomeric DNA.
Zhang WJ; Ou TM; Lu YJ; Huang YY; Wu WB; Huang ZS; Zhou JL; Wong KY; Gu LQ
Bioorg Med Chem; 2007 Aug; 15(16):5493-501. PubMed ID: 17574421
[TBL] [Abstract][Full Text] [Related]
5. Stabilization of the c-myc gene promoter quadruplex by specific ligands' inhibitors of telomerase.
Lemarteleur T; Gomez D; Paterski R; Mandine E; Mailliet P; Riou JF
Biochem Biophys Res Commun; 2004 Oct; 323(3):802-8. PubMed ID: 15381071
[TBL] [Abstract][Full Text] [Related]
6. Symmetrical bisbenzimidazoles with benzenediyl spacer: the role of the shape of the ligand on the stabilization and structural alterations in telomeric G-quadruplex DNA and telomerase inhibition.
Bhattacharya S; Chaudhuri P; Jain AK; Paul A
Bioconjug Chem; 2010 Jul; 21(7):1148-59. PubMed ID: 20536245
[TBL] [Abstract][Full Text] [Related]
7. [G-quadruplex DNA: myth or reality?].
Riou JF; Gomez D; Lemarteleur T; Trentesaux C
Bull Cancer; 2003 Apr; 90(4):305-13. PubMed ID: 12801813
[TBL] [Abstract][Full Text] [Related]
8. Resistance to senescence induction and telomere shortening by a G-quadruplex ligand inhibitor of telomerase.
Gomez D; Aouali N; Renaud A; Douarre C; Shin-Ya K; Tazi J; Martinez S; Trentesaux C; Morjani H; Riou JF
Cancer Res; 2003 Oct; 63(19):6149-53. PubMed ID: 14559794
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological evaluation of novel 4,5-bis(dialkylaminoalkyl)-substituted acridines as potent telomeric G-quadruplex ligands.
Laronze-Cochard M; Kim YM; Brassart B; Riou JF; Laronze JY; Sapi J
Eur J Med Chem; 2009 Oct; 44(10):3880-8. PubMed ID: 19467742
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, biophysical and biological evaluation of 3,6-bis-amidoacridines with extended 9-anilino substituents as potent G-quadruplex-binding telomerase inhibitors.
Schultes CM; Guyen B; Cuesta J; Neidle S
Bioorg Med Chem Lett; 2004 Aug; 14(16):4347-51. PubMed ID: 15261300
[TBL] [Abstract][Full Text] [Related]
11. Affinity and selectivity of G4 ligands measured by FRET.
De Cian A; Guittat L; Shin-ya K; Riou JF; Mergny JL
Nucleic Acids Symp Ser (Oxf); 2005; (49):235-6. PubMed ID: 17150720
[TBL] [Abstract][Full Text] [Related]
12. Remarkable interference with telomeric function by a G-quadruplex selective bisantrene regioisomer.
Folini M; Pivetta C; Zagotto G; De Marco C; Palumbo M; Zaffaroni N; Sissi C
Biochem Pharmacol; 2010 Jun; 79(12):1781-90. PubMed ID: 20206144
[TBL] [Abstract][Full Text] [Related]
13. Trisubstituted acridines as G-quadruplex telomere targeting agents. Effects of extensions of the 3,6- and 9-side chains on quadruplex binding, telomerase activity, and cell proliferation.
Moore MJ; Schultes CM; Cuesta J; Cuenca F; Gunaratnam M; Tanious FA; Wilson WD; Neidle S
J Med Chem; 2006 Jan; 49(2):582-99. PubMed ID: 16420044
[TBL] [Abstract][Full Text] [Related]
14. Porphyrin derivatives for telomere binding and telomerase inhibition.
Dixon IM; Lopez F; Estève JP; Tejera AM; Blasco MA; Pratviel G; Meunier B
Chembiochem; 2005 Jan; 6(1):123-32. PubMed ID: 15551357
[TBL] [Abstract][Full Text] [Related]
15. Selective interaction of ethidium derivatives with quadruplexes: an equilibrium dialysis and electrospray ionization mass spectrometry analysis.
Rosu F; De Pauw E; Guittat L; Alberti P; Lacroix L; Mailliet P; Riou JF; Mergny JL
Biochemistry; 2003 Sep; 42(35):10361-71. PubMed ID: 12950163
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of quindoline derivatives as G-quadruplex inducing and stabilizing ligands and potential inhibitors of telomerase.
Zhou JL; Lu YJ; Ou TM; Zhou JM; Huang ZS; Zhu XF; Du CJ; Bu XZ; Ma L; Gu LQ; Li YM; Chan AS
J Med Chem; 2005 Nov; 48(23):7315-21. PubMed ID: 16279791
[TBL] [Abstract][Full Text] [Related]
17. G-quadruplex preferentially forms at the very 3' end of vertebrate telomeric DNA.
Tang J; Kan ZY; Yao Y; Wang Q; Hao YH; Tan Z
Nucleic Acids Res; 2008 Mar; 36(4):1200-8. PubMed ID: 18158301
[TBL] [Abstract][Full Text] [Related]
18. Targeting telomeres and telomerase.
De Cian A; Lacroix L; Douarre C; Temime-Smaali N; Trentesaux C; Riou JF; Mergny JL
Biochimie; 2008 Jan; 90(1):131-55. PubMed ID: 17822826
[TBL] [Abstract][Full Text] [Related]
19. Isaindigotone derivatives: a new class of highly selective ligands for telomeric G-quadruplex DNA.
Tan JH; Ou TM; Hou JQ; Lu YJ; Huang SL; Luo HB; Wu JY; Huang ZS; Wong KY; Gu LQ
J Med Chem; 2009 May; 52(9):2825-35. PubMed ID: 19354252
[TBL] [Abstract][Full Text] [Related]
20. An evaluation cascade for G-quadruplex telomere targeting agents in human cancer cells.
Gunaratnam M; Neidle S
Methods Mol Biol; 2010; 613():303-13. PubMed ID: 19997892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
